STRYKER CORP is 68.2x more valuable than Pulse Biosciences, Inc. by market capitalization ($117.82 B vs $1.73 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | PLSE | SYK |
|---|---|---|
| Market cap | $1.73 B | $117.82 B |
| US-listed rank | #2212 | #130 |
| Revenue (latest FY) | $350.00K | $25.12B |
| Net income (latest FY) | -$72.78M | $3.25B |
| Net margin | -20794.6% | 12.9% |
| P/E (trailing FY) | - | 36.3 |
| SEC filings | 616 | 1,000 |
STRYKER CORP is 68.2x more valuable than Pulse Biosciences, Inc. by market capitalization ($117.82 B vs $1.73 B).
In their latest fiscal years, Pulse Biosciences, Inc. reported $350.00K in revenue while STRYKER CORP reported $25.12B.
Full pages: Pulse Biosciences, Inc. and STRYKER CORP, or browse the full rankings.